Listed

Molina Healthcare, Inc.

MOHNYSECIK 1179929FinancialsFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$11.08bnRevenue, Q3 FY2026, three months to 2026-09-30$11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 22, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$11.08bnRevenue, Q3 FY2026, three months to 2026-09-30$11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure−3.4% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin1.0%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $106.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure−0.2 pts on a year earlier
  • Net margin0.3%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $38.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure−0.3 pts on a year earlier
  • Diluted EPS$0.73Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure−51.7% on a year earlier
  • Free cash flow−$196.0mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: −$159.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Capital expenditure: $37.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Report this figure−20.2% on a year earlier

Last eight quarters

Full statements
Revenue$11.08bnOperating margin 1.0%
Diluted EPS$0.73, Q3 FY2026
Free cash flow−$196.0m, Q3 FY2026
Molina Healthcare, Inc., key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$bn10.5Revenue, Q4 FY2024, three months to 2024-12-31$10.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure11.1Revenue, Q1 FY2025, three months to 2025-03-31$11.15bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure11.4Revenue, Q2 FY2025, three months to 2025-06-30$11.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure11.5Revenue, Q3 FY2025, three months to 2025-09-30$11.48bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure11.4Revenue, Q4 FY2025, three months to 2025-12-31$11.38bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure10.8Revenue, Q1 FY2026, three months to 2026-03-31$10.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure10.9Revenue, Q2 FY2026, three months to 2026-06-30$10.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure11.1Revenue, Q3 FY2026, three months to 2026-09-30$11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%3.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $380.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Revenue: $10.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure3.9%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $433.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Revenue: $11.15bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure3.3%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $373.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Revenue: $11.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure1.2%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $137.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.48bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure(1.4%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$162.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Revenue: $11.38bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.8%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $83.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Revenue: $10.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure1.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $145.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Revenue: $10.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure1.0%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $106.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure
Net margin%2.4%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $251.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Revenue: $10.50bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure2.7%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $298.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.15bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure2.2%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $255.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure0.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $79.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.48bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure(1.4%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$160.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Revenue: $11.38bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $10.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure0.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $60.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $10.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure0.3%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $38.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Revenue: $11.08bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)5.45Diluted EPS, Q1 FY2025, three months to 2025-03-31$5.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure4.75Diluted EPS, Q2 FY2025, three months to 2025-06-30$4.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure1.51Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figurenot reported (Diluted EPS not reported)0.27Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure1.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0001179929-26-000039.Report this figure0.73Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-22, accession 0001179929-26-000045.Report this figure
Free cash flow$bn(0.2)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$224.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Capital expenditure: $11.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.2Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $190.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Capital expenditure: $22.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure(0.3)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$302.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0001179929-26-000039. Derived: 6-month figure less the 3-month figure.Capital expenditure: $42.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0001179929-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure(0.2)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$125.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Capital expenditure: $38.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Report this figure(0.3)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$298.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Capital expenditure: −$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001179929-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure1.1Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $1.08bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Capital expenditure: $27.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0001179929-26-000023.Report this figure(0.3)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$294.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0001179929-26-000039. Derived: 6-month figure less the 3-month figure.Capital expenditure: $30.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0001179929-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure(0.2)Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: −$159.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Capital expenditure: $37.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-22, accession 0001179929-26-000045. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$45.43bnOperating margin 1.7%
Diluted EPS$8.92, FY2025
Free cash flow−$636.0m, FY2025
Molina Healthcare, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$bn27.8Revenue, FY2021, twelve months to 2021-12-31$27.77bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-13, accession 0001179929-24-000033.Report this figure32.0Revenue, FY2022, twelve months to 2022-12-31$31.97bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-11, accession 0001179929-25-000023.Report this figure34.1Revenue, FY2023, twelve months to 2023-12-31$34.07bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure40.7Revenue, FY2024, twelve months to 2024-12-31$40.65bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure45.4Revenue, FY2025, twelve months to 2025-12-31$45.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%3.7%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $1.02bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-13, accession 0001179929-24-000033.Revenue: $27.77bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-13, accession 0001179929-24-000033.Report this figure3.7%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $1.17bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-11, accession 0001179929-25-000023.Revenue: $31.97bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-11, accession 0001179929-25-000023.Report this figure4.6%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $1.57bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $34.07bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure4.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $1.71bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $40.65bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure1.7%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $781.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $45.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure
Net margin%2.4%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $659.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-13, accession 0001179929-24-000033.Revenue: $27.77bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-13, accession 0001179929-24-000033.Report this figure2.5%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $792.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-11, accession 0001179929-25-000023.Revenue: $31.97bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-11, accession 0001179929-25-000023.Report this figure3.2%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $1.09bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $34.07bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure2.9%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $1.18bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $40.65bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure1.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $472.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0001179929-26-000005.Revenue: $45.43bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure
Diluted EPS$ per share11.25Diluted EPS, FY2021, twelve months to 2021-12-31$11.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-13, accession 0001179929-24-000033.Report this figure13.55Diluted EPS, FY2022, twelve months to 2022-12-31$13.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-11, accession 0001179929-25-000023.Report this figure18.77Diluted EPS, FY2023, twelve months to 2023-12-31$18.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure20.42Diluted EPS, FY2024, twelve months to 2024-12-31$20.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure8.92Diluted EPS, FY2025, twelve months to 2025-12-31$8.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure
Free cash flow$bn2.0Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $2.12bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-13, accession 0001179929-24-000033.Capital expenditure: $77.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-13, accession 0001179929-24-000033.Report this figure0.7Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $773.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-11, accession 0001179929-25-000023.Capital expenditure: $91.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-11, accession 0001179929-25-000023.Report this figure1.6Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $1.66bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001179929-26-000005.Capital expenditure: $84.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure0.5Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $644.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001179929-26-000005.Capital expenditure: $100.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure(0.6)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$535.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-10, accession 0001179929-26-000005.Capital expenditure: $101.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-10, accession 0001179929-26-000005.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Molina Healthcare, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$1.50bn6,572,156Added+203,130
AQR CAPITAL MANAGEMENT LLC2026-06-30$806.9m3,560,601Added+697,208
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$638.1m2,790,243Reduced−728
Capital World Investors2026-06-30$586.1m2,562,913Reduced−636,433
Lingotto Investment Management LLP2026-06-30$574.4m2,511,490New+2,511,490
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$538.6m2,355,261Added+45,031
VICTORY CAPITAL MANAGEMENT INC2026-06-30$453.0m1,980,615Reduced−90,084
FMR LLC2026-06-30$428.0m1,871,290Reduced−1,333,634
STATE STREET CORP2026-06-30$401.5m1,755,467Added+25,026
DIMENSIONAL FUND ADVISORS LP2026-06-30$318.7m1,393,338Reduced−1,544

Recent filings

All 1,983 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Molina Healthcare, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2213:23 ET10-QQuarterly reportPeriod 2026-09-300001179929-26-000045
2026-10-2120:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001179929-26-000042
2026-07-2314:21 ET10-QQuarterly reportPeriod 2026-06-300001179929-26-000039
2026-07-2220:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001179929-26-000036
2026-06-1020:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-020160
2026-05-1113:02 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001179929-26-000026
2026-05-0813:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-015766
2026-04-2314:11 ET10-QQuarterly reportPeriod 2026-03-310001179929-26-000023
2026-04-2220:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001179929-26-000020
2026-03-2320:18 ETDEF 14AProxy statementPeriod 2026-03-230001179929-26-000014

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 10, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1179929
Tickers
MOH
Exchange
NYSE
SIC code
6324 Hospital & Medical Service Plans
Sector
Financials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
MOLINA HEALTHCARE INC (to 2019-07-03)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.